Estradiol-mediated protection against high-fat diet induced anxiety and obesity is associated with changes in the gut microbiota in female mice
Steve Neeleman, HealthEquity Founder, said in a press release
When GLP-1s Are Not Appropriate Some situations are absolute contraindications: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Pregnancy or breastfeeding , or actively trying to conceive Known hypersensitivity to the medication Others require a careful risk-benefit conversation rather than an automatic no: a history of pancreatitis, gastroparesis or significant GI disease, active gallbladder disease, advanced kidney disease, type 1 diabetes, proliferative diabetic retinopathy, or a history of eating disorders
It also cites an unnamed 2023 observational study reporting larger pain-score improvements at higher weight loss, but since that study is never identified, its specific figures cannot be verified
In clinical trials, patients who received Semaglutide lost an average of 15% to 20% of their body weight over the course of a year